Board members and private and institutional investors hire RNA Advisors when they wish to better time and position their buy-side and sell-side strategies for their investments in early-stage life sciences companies. Buy-side investors often seek advisory support for investments and acquisitions in the Life Sciences and early-stage private equity investors as well as strategic investors and late-stage venture capital investors need outsourced analytic support and opportunity evaluation, due diligence and pricing evaluations. Our work often extends into ongoing portfolio company support, opinion advisories, royalty/licensing evaluations, de-SPAC valuation opinions, and deal support.
